Skip to main content
Premium Trial:

Request an Annual Quote

CDC Commits $90M to Create Public Health Pathogen Genomics Research Centers

NEW YORK — The US Centers for Disease Control and Prevention has earmarked $90 million to fund the establishment of six US Public Health Pathogen Genomics Centers of Excellence that will be tasked with developing technologies to address microbial threats to public health.

The centers will work with academic and public health organizations to advance pathogen genomics and molecular epidemiology to improve the control of, and response to, infectious disease, the CDC said.

Grant funding is expected to be awarded in August 2022, with projects beginning the following month.

Earlier this year, the White House announced that the Biden administration had committed $1.7 billion to support the surveillance of SARS-CoV-2 variants, including viral genome sequencing, genomic epidemiology centers, and new bioinformatics infrastructure.

At the time, the government said that $400 million would be used to create six Centers of Excellence in Genomic Epidemiology that will work with state health departments and academic institutes to develop new genomic epidemiology technologies such as surveillance tools to track pathogens and bioinformatic workflows.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.